← All organizations

Brii Biosciences

For profit

Also known as: Brii Biosciences, Inc. | Brii Biosciences Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2024

Timeline

2010s

Jun 1, 2017
Brii Biosciences— Founded

Drugs by trial phase (11 distinct, 14 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

brii-297

Indications

Studied for

Recent trials (20)

NCT06650852OfficialPhase 2Nov 30, 2024
NCT06650852Lead sponsorPhase 2Nov 30, 2024
NCT06491563Lead sponsorPhase 2Aug 31, 2024
NCT06491563OfficialPhase 2Aug 31, 2024
NCT06057012Lead sponsorPhase 2Sep 29, 2023
NCT05970289Study directorPhase 2Aug 22, 2023
NCT05970289Lead sponsorPhase 2Aug 22, 2023
NCT05845840Lead sponsorPhase 1May 15, 2023
NCT04787211Lead sponsorPhase 2Jun 20, 2021
NCT04749368Lead sponsorPhase 2Apr 12, 2021
NCT04749368Study directorPhase 2Apr 12, 2021
NCT04770467Lead sponsorPhase 2Feb 28, 2021
NCT04770467Study directorPhase 2Feb 28, 2021
NCT04691180Lead sponsorPhase 1Dec 31, 2020
NCT05780424CollaboratorPhase 3Dec 16, 2020

Details

Founded: San Francisco, CA, US Jun 1, 2017
Last known activity: Nov 30, 2024